Biogen's NURTURE Data, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Seeking Alpha
SummaryBiogen reports positive data from the NURTURE study.Magenta quits inherited metabolic disorder study.Clovis completes enrolment in RUBRACA study.Biogen Reports Positive Data from Landmark NURTURE StudyBiogen Inc. (BIIBreportedAs of February 2020, all 25 patientstreatedThe patients enrolled in the study received their first dose of SPINRAZA before they were 6 weeks old. The new data showed that the participants who were previously able to walk independently and walk with assistance sustained their ability over the course of 11 months since the last data cut. Over the 11 months of follow-up, one child gained the ability to walk with assistance.Patients with two copies of SMN2 were able to score and advance on the Hammersmith Functional Motor Scale Expanded scale. This development is atypical to the natural history of the disease. The drug candidate was found to be well-tolerated and did not show any new safety concerns over the extended follow-up period. further, no patient had t
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis Publishes 2023 Corporate Responsibility Report [Yahoo! Finance]Yahoo! Finance
- Ionis Publishes 2023 Corporate Responsibility ReportPR Newswire
- n-Lorem Foundation Partners with Hongene Biotech Corporation to Support the Discovery of Personalized ASO Medicines for Nano-rare Patients [Yahoo! Finance]Yahoo! Finance
- Ionis to hold first quarter 2024 financial results webcastPR Newswire
- Bepirovirsen for Chronic Hepatitis B Drug Pipeline Report 2024: 7MM Market Size, Forecast, and Emerging Insights 2019-2032 [Yahoo! Finance]Yahoo! Finance
IONS
Earnings
- 2/21/24 - Beat
IONS
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- IONS's page on the SEC website